Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangxi Tiantianle Pharmaceutical is a Chinese pharmaceutical company that specializes in the development and production of Traditional Chinese Medicine (TCM) and chemical drugs. Based in Guilin, the company is widely recognized for its expertise in respiratory and pediatric health, with flagship products such as Compound Licorice Tablets and various pediatric granules. In 2014, the company was acquired by Guilin Sanjin Pharmaceutical, a prominent leader in the Chinese TCM industry, to enhance its manufacturing scale and product diversity. Guangxi Tiantianle operates modern, GMP-certified production facilities and maintains a robust distribution network across mainland China. Its portfolio focuses on high-demand therapeutic areas including gastroenterology, cough and cold, and children's health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangxi Tiantianle Pharmaceutical.